
Nanogrow is a biotech company that builds an end-to-end nanobody bioengineering platform focused on discovering and developing next-gen biologics. We leverage VHH technology to overcome the limitations of traditional antibody-based medicines (mAbs), enabling localized delivery and high-affinity targeting in complex indications. Our platform specializes in single-domain antibodies (VHH), designed for superior tissue penetration and modular bioengineering compared to standard mAbs. We are advancing a robust R&D pipeline targeting high-unmet-need areas, including: Oncology: Solid tumors and…
Annual RevenueBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.